Acinetobacter baumannii is emerging as a serious nosocomial pathogen with multidrug
resistance that has made it difficult to cure and development of efficacious treatment against …

Acinetobacter baumannii, a prominent pathogen responsible for chronic infections in the
blood, urinary tract, and lungs, has a high mortality due to its virulence and limited …

Antibiotic resistance (AR) is the result of microbes' natural evolution to withstand the action
of antibiotics used against them. AR is rising to a high level across the globe, and novel …

In the last decade, Multi-drug resistance (MDR)-associated infections of Acinetobacter
baumannii have grown worldwide. A cost-effective preventative strategy against this …

Acinetobacter baumannii is an emerging opportunistic bacterium associated with
nosocomial infections in intensive care units. The alarming increase in infections caused by …

Infections caused by multi-drug resistance Acinetobacter baumannii are increasing
worldwide. Discovery of the vaccine against this bacterium as a cost-effective and preventive …

Background Acinetobacter baumannii, a nosocomial pathogen, is considered as a common
cause of hospital and community-acquired infections. Emerging multidrug-resistance in this …

As one of the most influential and troublesome human pathogens, Acinetobacter baumannii
(A. baumannii) has emerged with many multidrug-resistant strains. After collecting 33 …

Acinetobacter baumannii is an emerging multi-drug resistant pathogen causing significant
mortality in hospitalized ICU patients which demands developing new methods for …

Acinetobacter baumannii is a problematic nosocomial pathogen. The resistance to a wide
range of antimicrobial agents, attributable to its biofilm phenotype, makes the treatment very …